Kintara Therapeutics Inc
KTRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.99M
Close$
Share Statistics
| Market cap | $11.99 Million |
|---|---|
| Enterprise Value | $6.15 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.21 |
| Beta | 0.81 |
| Outstanding Shares | 60,010,237 |
Return
| Return on Equity | -132.97% |
|---|---|
| Return on Assets | -103.81% |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -4.38 |
|---|---|
| PEG | -33.51 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.07 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 14, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kintara Therapeutics Inc
CEO: Saiid Zarrabian